This compound is a peptide-based active pharmaceutical ingredient used in pharmaceutical manufacturing. Its structure contains multiple amino acid residues, including a D-serine and a D-leucine, resulting in a highly flexible molecule with numerous hydrogen bond donors and acceptors.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 62621-13-0
Deslorelin
pharmaceutical raw material
Meglumine
pharmaceutical raw material
Iopamidol
pharmaceutical raw material
Cefoperazone
pharmaceutical raw material
Cefoperazone sodium
pharmaceutical raw material
Leuprolide acetate
pharmaceutical raw material
(Des-Gly10,D-Tyr5,D-Leu6,Pro-NHEt9)-LHRH
research compound
(des-gly10,d-leu6,d-leu7,pro-nhet9)-lhrh trifluoroacetate salt
pharmaceutical raw material
(2S)-N-[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
GFIJNRVAKGFPGQ-WQVASJQXSA-N
CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6